A novel form of Epstein-Barr virus latency in normal B cells in vivo

Adams, 1979, The state of the virus genome in transformed cells and its relationship to host cell DNA, 156

Ambinder, 1990, Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens, Mol. Cell. Probes, 4, 397, 10.1016/0890-8508(90)90030-4

Baer, 1984, DNA sequence and expression of the B95-8 Epstein-Barr virus genome, Nature, 310, 207, 10.1038/310207a0

Coen, 1990, Quantification of rare DNAs by the polymerase chain reaction, 15.3.1

Freedman, 1987, B7, a B-cell-restricted antigen that identifies preactivated B cells, J. Immunol., 139, 3260, 10.4049/jimmunol.139.10.3260

Gratama, 1988, Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency, 85, 8693

Gregory, 1987, Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype, J. Immunol., 139, 313, 10.4049/jimmunol.139.1.313

Hurley, 1988, B cell activation and the establishment of Epstein-Barr virus latency, J. Exp. Med., 168, 2059, 10.1084/jem.168.6.2059

Jones, 1988, T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections, N. Engl. J. Med., 318, 733, 10.1056/NEJM198803243181203

Khanna, 1992, Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development, J. Exp. Med., 176, 169, 10.1084/jem.176.1.169

Kieff, 1990, Epstein-Barr Virus and its replication, 1889

Klein, 1989, Viral latency and transformation: the strategy of Epstein-Barr virus, Cell, 58, 5, 10.1016/0092-8674(89)90394-2

Klein, 1994, Epstein-Barr virus strategy in normal and neoplastic B cells, Cell, 77, 791, 10.1016/0092-8674(94)90125-2

Klein, 1985, Evolution of tumours and the impact of molecular oncology, Nature, 315, 190, 10.1038/315190a0

Lam, 1991, Circulating Epstein-Barr virus-carrying B cells in acute malaria, Lancet, 337, 876, 10.1016/0140-6736(91)90203-2

Lewin, 1987, Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth, Int. J. Cancer, 39, 472, 10.1002/ijc.2910390411

Miller, 1990, EBV biology, pathogenesis and medical aspects, 1921

Rickinson, 1985, The Epstein-Barr virus as a model of virus-host interactions, Br. Med. Bull., 41, 75, 10.1093/oxfordjournals.bmb.a072030

Rowe, 1987, Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells, EMBO J., 6, 2743, 10.1002/j.1460-2075.1987.tb02568.x

Saito, 1989, Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome, J. Exp. Med., 169, 2191, 10.1084/jem.169.6.2191

Schlossman, 1994, CD antigens, 1993, Immunol. Today, 15, 98, 10.1016/0167-5699(94)90149-X

Sixbey, 1983, Replication of Epstein-Barr virus in human epithelial cells infected in vitro, Nature, 306, 480, 10.1038/306480a0

Sugden, 1979, Epstein-Barr virus DNA is amplified in transformed lymphocytes, J. Virol., 31, 590, 10.1128/JVI.31.3.590-595.1979

Telenti, 1990, Detection of Epstein-Barr virus by polymerase chain reaction, J. Clin. Microbiol., 28, 2187, 10.1128/JCM.28.10.2187-2190.1990

Tew, 1980, The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells, Immunol. Rev., 53, 175, 10.1111/j.1600-065X.1980.tb01044.x

Thomas, 1990, Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals, Transplantation, 49, 944, 10.1097/00007890-199005000-00022

Thorley-Lawson, 1989, Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases, Biochim. Biophys. Acta, 948, 263

Wagner, 1992, Detection and quantitation of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction, J. Clin. Microbiol., 30, 2826, 10.1128/JCM.30.11.2826-2829.1992

Wyatt, 1992, BCL2 oncogene translocation is mediated by a χ-like consensus, J. Exp. Med., 175, 1575, 10.1084/jem.175.6.1575

Yao, 1985, In vitro analysis of the Epstein-Barr virus: host balance in long-term renal allograft recipients, Int. J. Cancer, 35, 43, 10.1002/ijc.2910350108

Yao, 1989, Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers, Int. J. Cancer, 43, 67, 10.1002/ijc.2910430115

Yao, 1991, Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities, Int. J. Cancer, 48, 253, 10.1002/ijc.2910480217

York, 1994, A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes, Cell, 77, 525, 10.1016/0092-8674(94)90215-1